Mediterranean, fasting or DASH? Exploring promising metabolic benefits for management of MASLD

Imagine a condition affecting nearly one-third of the global population, often silently progressing, and deeply intertwined with prevalent health issues like obesity and type 2 diabetes. This is metabolic dysfunction-associated steatotic liver disease, or MASLD, previously known as non-alcoholic fatty liver disease (NAFLD). It's characterized by an excessive accumulation of fat in the liver, which can lead to more severe liver pathologies, including inflammation, fibrosis, and even liver cancer.

👉 Full Story